| Marketing of unproven stem cell–based interventions: a call to action D Sipp, T Caulfield, J Kaye, J Barfoot, C Blackburn, S Chan, M De Luca, ... Science translational medicine 9 (397), eaag0426, 2017 | 182 | 2017 |
| Medical tourism and national health care systems: an institutionalist research agenda D Béland, A Zarzeczny Globalization and health 14 (1), 68, 2018 | 104 | 2018 |
| Health misinformation and the power of narrative messaging in the public sphere T Caulfield, AR Marcon, B Murdoch, JM Brown, ST Perrault, J Jarry, ... Canadian Journal of Bioethics 2 (2), 52-60, 2019 | 86 | 2019 |
| iPS cells: mapping the policy issues A Zarzeczny, C Scott, I Hyun, J Bennett, J Chandler, S Chargé, H Heine, ... Cell 139 (6), 1032-1037, 2009 | 86 | 2009 |
| Stem cell tourism and doctors' duties to minors—a view from Canada A Zarzeczny, T Caulfield The American Journal of Bioethics 10 (5), 3-15, 2010 | 78 | 2010 |
| Emerging ethical, legal and social issues associated with stem cell research & and the current role of the moral status of the embryo A Zarzeczny, T Caulfield Stem Cell Reviews and Reports 5, 96-101, 2009 | 76 | 2009 |
| Stem cell clinics in the news A Zarzeczny, C Rachul, M Nisbet, T Caulfield Nature biotechnology 28 (12), 1243-1246, 2010 | 72 | 2010 |
| Media, politics and science policy: MS and evidence from the CCSVI trenches D Pullman, A Zarzeczny, A Picard BMC medical ethics 14, 1-9, 2013 | 64 | 2013 |
| Exploiting science? A systematic analysis of complementary and alternative medicine clinic websites’ marketing of stem cell therapies B Murdoch, A Zarzeczny, T Caulfield BMJ open 8 (2), e019414, 2018 | 59 | 2018 |
| How to peddle hope: an analysis of YouTube patient testimonials of unproven stem cell treatments B Hawke, AR Przybylo, D Paciulli, T Caulfield, A Zarzeczny, Z Master Stem Cell Reports 12 (6), 1186-1189, 2019 | 52 | 2019 |
| The stem cell research environment: a patchwork of patchworks T Caulfield, A Zarzeczny, J McCormick, T Bubela, C Critchley, E Einsiedel, ... Stem Cell Reviews and Reports 5, 82-88, 2009 | 51 | 2009 |
| The future of artificial intelligence in medicine: medical-legal considerations for health leaders S Jassar, SJ Adams, A Zarzeczny, BE Burbridge Healthcare Management Forum 35 (3), 185-189, 2022 | 46 | 2022 |
| Stem cell tourism and Canadian family physicians T Caulfild, A Zarzeczny, Toronto Stem Cell Working Group Canadian Family Physician 58 (4), 365-368, 2012 | 40 | 2012 |
| Research ethics and stem cells: Is it time to re‐think current approaches to oversight? T Caulfield, K Kamenova, U Ogbogu, A Zarzeczny, J Baltz, S Benjaminy, ... EMBO reports 16 (1), 2-6, 2015 | 38 | 2015 |
| What's missing? Discussing stem cell translational research in educational information on stem cell “tourism” Z Master, A Zarzeczny, C Rachul, T Caulfield Journal of Law, Medicine & Ethics 41 (1), 254-268, 2013 | 35 | 2013 |
| Professional regulation: a potentially valuable tool in responding to “stem cell tourism” A Zarzeczny, T Caulfield, U Ogbogu, P Bell, VA Crooks, K Kamenova, ... Stem Cell Reports 3 (3), 379-384, 2014 | 34 | 2014 |
| The evolution of policy issues in stem cell research: an international survey T Caulfield, C Rachul, A Zarzeczny Stem Cell Reviews and Reports 8, 1037-1042, 2012 | 34 | 2012 |
| Stem cell research policy and iPS cells T Caulfield, C Scott, I Hyun, R Lovell-Badge, K Kato, A Zarzeczny nature methods 7 (1), 28-33, 2010 | 32 | 2010 |
| The rise of neuroskepticism C Rachul, A Zarzeczny International Journal of Law and Psychiatry 35 (2), 77-81, 2012 | 30 | 2012 |
| “Neurohype” and the Name Game: Who's to Blame? T Caulfield, C Rachul, A Zarzeczny AJOB Neuroscience 1 (2), 13-15, 2010 | 29 | 2010 |
